Glenmark Pharma gets USFDA nod for generic version of Nexium to treat acid reflux
The approved products Esomeprazole Magnesium delayed-release capsule is a generic version of AstraZeneca Pharmaceuticals' Nexium delayed-release capsules.
New Delhi: Glenmark Pharmaceuticals on May 14 said it has received final approval from the US health regulator for a generic version of AstraZeneca's Nexium, used to treat acid reflux.
Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food & Drug Administration (US FDA) for Esomeprazole Magnesium delayed-release capsules USP in the strengths of 20 mg and 40 mg, the company said in a BSE filing.
The approved products is a generic version of AstraZeneca Pharmaceuticals' Nexium delayed-release capsules.
Also Read: Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd